Routine molecular point-of-care testing improves influenza detection in hospitalised adults
14 January, 2021
The multicentre, open-label, randomised controlled trial evaluating the molecular point-of-care test-and-treat strategy for influenza (FluPOC) has shown that the routine use of this strategy improves influenza detection and other clinical...
The multicentre, open-label, randomised controlled trial evaluating the molecular point-of-care test-and-treat strategy for influenza (FluPOC) has shown that the routine use of this strategy improves influenza detection and other clinical...